| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |